Systemic Bioavailability of Sublingual Atropine Ophthalmic Solution a Phase I Study in Healthy Volunteers with Implications for Use as a Contingency
Schwartz, M., Raulli, R., Laney, J., et al.
(2022).
Systemic Bioavailability of Sublingual Atropine Ophthalmic Solution: a Phase I Study in Healthy Volunteers with Implications for Use as a Contingency Medical Countermeasure.
Journal of Medical Toxicology. 18(3):187-197.
The authors conducted a phase I study to understand whether atropine administered under the tongue could be a successful medical countermeasure against organophosphorus nerve agent and organophosphate pesticide toxicity. They found that sublingual atropine may be an effective countermeasure for this nerve agent.
Favorite:
Login to favorite the article